About Monitoring
暂无分享,去创建一个
[1] M. Woodward,et al. Blood glucose and risk of cardiovascular disease in the Asia Pacific region. , 2004, Diabetes care.
[2] H. Keen,et al. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes , 2001, Diabetologia.
[3] Liu Xinbing,et al. Intensive insulin therapy for the critically ill patients with stress hyperglycemia , 2008 .
[4] A. Calle-Pascual,et al. Nontraumatic lower extremity amputations in diabetic and non-diabetic subjects in Madrid, Spain. , 1997, Diabetes & metabolism.
[5] C. Pepine,et al. A calcium antagonist vs. a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the international verapamil-trandolapril study (INVEST): a randomized controlled trial , 2004 .
[6] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[7] L. Abraham,et al. Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women. , 2005, American journal of epidemiology.
[8] B. Brenner,et al. Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study. , 2004, Diabetes care.
[9] A. Beydoun,et al. Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients With Diabetes Mellitus: a Randomized Controlled Trial , 1999 .
[10] Caroline A Crowther,et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. , 2005, The New England journal of medicine.
[11] U. Kabadi,et al. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials. , 1996, Archives of internal medicine.
[12] H. Yki-Järvinen,et al. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group. , 2000, Diabetes care.
[13] D. Bennett,et al. Blood pressure and cardiovascular disease in the Asia Pacific region. , 2003, Journal of hypertension.
[14] K. Kosaka,et al. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. , 2005, Diabetes research and clinical practice.
[15] L. Sjöström,et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. , 2004, Diabetes care.
[16] R. Dubner,et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood , 1987, Neurology.
[17] M. Weir,et al. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study , 2004, Diabetologia.
[18] Steven Snapinn,et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol , 2002, The Lancet.
[19] J Herlitz,et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. , 2005, European heart journal.
[20] E. Barrett-Connor,et al. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. , 2002, Archives of internal medicine.
[21] K. Alberti,et al. The Care of the Diabetic Patient During Surgery , 2004 .
[22] D. Cooper,et al. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study , 1999, The Lancet.
[23] Sarah Parish,et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.
[24] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[25] M J Koziel,et al. Pulmonary complications of diabetes mellitus. Pneumonia. , 1995, Infectious disease clinics of North America.
[26] P. Small,et al. Tuberculosis and diabetes in southern Mexico. , 2004, Diabetes care.
[27] T. Wilt,et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. , 1999, The New England journal of medicine.
[28] B. Howard,et al. Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.
[29] W. Reitsma,et al. Walking training for intermittent claudication in diabetes. , 1999, Diabetes care.
[30] D. Feig,et al. Type 2 diabetes in pregnancy: a growing concern , 2002, The Lancet.
[31] M. C. Leske,et al. The prevalence of diabetic retinopathy among adults in the United States. , 2004, Archives of ophthalmology.
[32] T. Buchanan,et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. , 2002, Diabetes.
[33] J Herlitz,et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. , 1995, Journal of the American College of Cardiology.
[34] Teven,et al. EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES AND NEPHROPATHY EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY , 2001 .
[35] G. A. Holloway,et al. Prevention of amputation by diabetic education. , 1989, American journal of surgery.